The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides
Open accessAbstract
As the concentrations of highly consumed nutrients, particularly glucose, are generally lower in tumours than in normal tissues, cancer cells must adapt their metabolism to the tumour microenvironment. A better understanding of these adaptations might reveal cancer cell liabilities that can be exploited for therapeutic benefit. Here we developed a continuous-flow culture apparatus (Nutrostat) for maintaining proliferating cells in low-nutrient media for long periods of time, and used it to undertake competitive proliferation assays on a pooled collection of barcoded cancer cell lines cultured in low-glucose conditions. Sensitivity to low glucose varies amongst cell lines, and an RNA interference (RNAi) screen pinpointed mitochondrial oxidative phosphorylation (OXPHOS) as the major pathway required for optimal proliferation in low glucose. We found that cell lines most sensitive to low glucose are defective in the OXPHOS upregulation that is normally caused by glucose limitation as a result of either mitochondrial DNA (mtDNA) mutations in complex I genes or impaired glucose utilization. These defects predict sensitivity to biguanides, antidiabetic drugs that inhibit OXPHOS, when cancer cells are grown in low glucose or as tumour xenografts. Notably, the biguanide sensitivity of cancer cells with mtDNA mutations was reversed by ectopic expression of yeast NDI1, a ubiquinone oxidoreductase that allows bypass of complex I function. Thus, we conclude that mtDNA mutations and impaired glucose utilization are potential biomarkers for identifying tumours with increased sensitivity to OXPHOS inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These findings confirm previous studies that analyzed inhibition of either glycolysis or OXPHOS, and observed an increase in the activity of the other pathway (Hao et al., 2010; Jose et al., 2011; Birsoy et al., 2014; Dykens et al., 2008).”
From Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis (2019) · cites this paper as Birsoy et al., 2014
In the citing paper
“Cancer cells with reduced OXPHOS due to either mutated mitochondrial DNA or impaired glucose utilization were unable to initiate this adaptive response, and were thus particularly sensitive to glucose deprivation to one-tenth of normal levels (Birsoy et al., 2014).”
From Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis (2019) · cites this paper as Birsoy et al., 2014
In the citing paper
“These results are consistent with previous studies reporting the synergism of the metformin/low glucose combination (Birsoy et al., 2014; Zhuang et al., 2014).”
From Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis (2019) · cites this paper as Birsoy et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
Possemato, R., Marks, K. M., Shaul, Y. D., Pacold, M. E., Kim, D., Birsoy, K., Sethumadhavan, S., Woo, H.-K., Jang, H. G., Jha, A. K., et al. (2011) · Nature · doi:10.1038/nature10350 · Cited by 1,683
Self-citationMetabolite profiling identifies a key role for glycine in rapid cancer cell proliferation
Jain, M., Nilsson, R., Sharma, S., Madhusudhan, N., Kitami, T., Souza, A. L., Kafri, R., Kirschner, M. W., Clish, C. B., & Mootha, V. K. (2012) · Science · doi:10.1126/science.1218595 · Cited by 1,403
Self-citationEl-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399
Hirayama, A., Kami, K., Sugimoto, M., Sugawara, M., Toki, N., Onozuka, H., Kinoshitá, T., Saito, N., Ochiai, A., Tomita, M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4806 · Cited by 965
Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
DeCensi, A., Puntoni, M., Goodwin, P., Cazzaniga, M., Gennari, A., Bonanni, B., & Gandini, S. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0157 · Cited by 918
Observations on the carbohydrate metabolism of tumours
Crabtree, H. G. (1929) · Biochemical Journal · doi:10.1042/bj0230536 · Cited by 864
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 710
Mehazri, L., Shpungin, S., Bel, S., & Nir, U. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073387 · Cited by 10
Kaczmarek, K., Wieckiewicz, J., Węglarczyk, K., Siedlar, M., & Baran, J. (2021) · Cancers · doi:10.3390/cancers13123004 · Cited by 11
Multifaceted roles of mitochondrial dysfunction in diseases: from powerhouses to saboteurs
Prabhu, S. S., Nair, A. S., & Nirmala, S. V. (2023) · Archives of Pharmacal Research · doi:10.1007/s12272-023-01465-y · Cited by 13
Repas, J., Peternel, L., Sourij, H., & Pavlin, M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1216193 · Cited by 12
The effects of restricted glycolysis on stem-cell like characteristics of breast cancer cells
Banerjee, A., Arvinrad, P., Darley, M., Laversin, S. A., Parker, R., Rose-Zerilli, M. J. J., Townsend, P. A., Cutress, R., Beers, S. A., Houghton, F. D., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25299 · Cited by 11
Down-regulation of PCK2 inhibits the invasion and metastasis of laryngeal carcinoma cells.
Hu, Y., Deng, K., Pan, M., Liu, S., Li, W., Huang, J., Yao, J., & Zuo, J. (2020) · PubMed Central · Cited by 10
Chen, M., Hsu, L.-L., Wang, S., Pan, Y.-L., Lo, J., Yeh, T.-S., Tseng, L., & Lee, H. (2021) · Biomedicines · doi:10.3390/biomedicines9091101 · Cited by 12
Orang, A., Ali, S. R., Petersen, J., McKinnon, R. A., Aloia, A. L., & Michael, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-06587-9 · Cited by 11
Cost-Effective Real-Time Metabolic Profiling of Cancer Cell Lines for Plate-Based Assays
Blaszczak, W., Tan, Z., & Swietach, P. (2021) · Chemosensors · doi:10.3390/chemosensors9060139 · Cited by 10
He, Z., Teng, F., Yang, Y., Guo, R., Wu, M., Han, F., Tian, H., Wang, J., Hu, Y., Jiang, Y., et al. (2025) · Nature Structural & Molecular Biology · doi:10.1038/s41594-025-01710-6 · Cited by 14
Tao, T., Feng, X., Yang, Y., Liu, B., Liang, J., Chen, Z., Wang, S., Zhao, J., Yang, X., Huo, L., et al. (2026) · Nature Cell Biology · doi:10.1038/s41556-026-01905-z · Cited by 11
Cancer in Ecuadorian subjects with Laron syndrome (ELS)
Guevara‐Aguirre, J., Peña, G., Pazmiño, G., Acosta, W., Saavedra, J., Lescano, D., Guevara, A., & Gavilanes, A. W. D. (2023) · Endocrine Related Cancer · doi:10.1530/erc-22-0389 · Cited by 12
Adapt and shape: metabolic features within the metastatic niche
Pranzini, E., Ippolito, L., Pardella, E., Giannoni, E., & Chiarugi, P. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.07.016 · Cited by 10
Harhai, M., Foged, M. M., Zarges, C., Landoni, J. C., Chollet, S., Simonelli, M., Recazens, E., Lisci, M., Laban, N., Manley, S., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116069 · Cited by 10
Characterization of human gastric adenocarcinoma cell lines established from peritoneal ascites
Mytar, B., Stec, M., Szatanek, R., Węglarczyk, K., Szewczyk, K., Szczepanik, A., Drabik, G., Baran, J., Siedlar, M., & Baj‐Krzyworzeka, M. (2018) · Oncology Letters · doi:10.3892/ol.2018.7995 · Cited by 10
Anti-VEGF therapy selects for clones resistant to glucose starvation in ovarian cancer xenografts
Boso, D., Tognon, M., Curtarello, M., Minuzzo, S. A., Piga, I., Brillo, V., Lazzarini, E., Carlet, J., Marra, L., Trento, C., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02779-x · Cited by 10
Alkinani, T. A., Bajgiran, F. A., Rezaei, M., Maivan, A. M., Golrokh, F. J., Bejarbaneh, M., Mojdehi, S. R., Gorji, S., Ghasemian, R., Sarai, M. D. J. P., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e23419 · Cited by 10
Park, G. B., Jeong, J.-Y., Choi, S., Yoon, Y. S., & Kim, D. (2021) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000001215 · Cited by 10
Marciano, O., Mehazri, L., Shpungin, S., Varvak, A., Zacksenhaus, E., & Nir, U. (2021) · Cells · doi:10.3390/cells10010097 · Cited by 10
Does photobiomodulation require glucose to work effectively?
Kam, J. H., & Mitrofanis, J. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.385290 · Cited by 9
Mitochondrial transcription elongation factor TEFM promotes malignant progression of gliomas
Wang, Y., Hu, W., Zhou, B., Zhao, Y. Q., Tang, Y., Deng, Z., & Chen, M. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03617-6 · Cited by 9
Urine Metabolic Fingerprints Encode Subtypes of Kidney Diseases
Yang, J., Wang, R., Huang, L., Zhang, M., Niu, J., Bao, C., Shen, N., Dai, M., Guo, Q., Wang, Q., et al. (2019) · Angewandte Chemie · doi:10.1002/ange.201913065 · Cited by 9
Bruhn, C., Bastianello, G., & Foiani, M. (2022) · Communications Biology · doi:10.1038/s42003-022-03846-3 · Cited by 9
Zhang, L., Liu, Z., Yu, L., Peng, W., Chen, Y., & Zhang, S. (2022) · Biomaterials Science · doi:10.1039/d2bm01267g · Cited by 9
Combination strategies to target metabolic flexibility in cancer
Krstić, J., Schindlmaier, K., & Prokesch, A. (2022) · International review of cytology · doi:10.1016/bs.ircmb.2022.03.001 · Cited by 9
Kurelac, I., de Biase, D., Calabrese, C., Ceccarelli, C., Ng, C. K. Y., Lim, R. S., Mackay, A. G., Weigelt, B., Porcelli, A. M., Reis-Filho, J. S., et al. (2015) · Europe PMC (PubMed Central) · Cited by 9
Molecular Genetics of Dysregulated pH Homeostasis
Chi, J. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1683-2 · Cited by 9
Xie, Y., Zhang, W., Guo, L., Kril, L. M., Begley, K. L., Sviripa, V. M., Chen, X., Liu, X., Lee, E. Y., He, D., et al. (2021) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-1017 · Cited by 10
Myllymäki, H., Kelly, L., Elliot, A. M., Carter, R. N., Johansson, J. A., Chang, K.-M., Cholewa-Waclaw, J., Morton, N. M., & Feng, Y. (2024) · Oncogenesis · doi:10.1038/s41389-024-00507-4 · Cited by 8
Zhao, X. H., Han, M. M., Yan, Q., Yue, Y. M., Ye, K., Zhang, Y. Y., Liu, T., Xu, L., Shi, X., La, T., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07334-4 · Cited by 9
The Research Progress of Metformin Regulation of Metabolic Reprogramming in Malignant Tumors
Sui, Q., Yang, H., Hu, Z., Jin, X., Chen, Z., Jiang, W., & Sun, F. (2024) · Pharmaceutical Research · doi:10.1007/s11095-024-03783-2 · Cited by 8
Zhang, X., Cheng, T., Cho, H., Lu, W., Denoyer, D., McMillan, P. J., Shobhana, K., Varshney, S., Williamson, N. A., & Stewart, A. G. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107519 · Cited by 8
PRPS activity tunes redox homeostasis in Myc-driven lymphoma
MacMillan, A. C., Karki, B., Yang, J., Gertz, K. R., Zumwalde, S., Patel, J. A., Czyzyk-Krzeska, M., Meller, J., & Cunningham, J. T. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103649 · Cited by 8
Sakai, T., Matsuo, Y., Okuda, K., Hirota, K., Tsuji, M., Hirayama, T., & Nagasawa, H. (2021) · Scientific Reports · doi:10.1038/s41598-021-83708-w · Cited by 8
Huntingtin-associated protein 1 is a potential tumor suppressor for gastric cancer
Qu, Y.-M., Chen, A., Zhao, X., Wang, Z., Guo, D., Shao, S.-L., Tao, Y.-Y., Li, Q.-J., Wang, M., & Ma, W. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-08090-w · Cited by 8
Akdoğan, E., Tardu, M., Garipler, G., Baytek, G., Kavaklı, İ. H., & Dunn, C. D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146511 · Cited by 8
Bizjak, M., Malavašič, P., Pirkmajer, S., & Pavlin, M. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.05.090 · Cited by 8
Energy metabolism modulation by biguanides in comparison with rotenone in rat liver and heart
Heinz, S., Freyberger, A., Lawrenz, B., Schladt, L., Schmuck, G., & Ellinger-Ziegelbauer, H. C. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02519-1 · Cited by 8
Yang, Q., Guo, J.-A., Zhang, K., Li, S., Xia, W.-Y., Wang, D.-X., Xie, L., Wang, J., & Wu, Q. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413506 · Cited by 7
Advances in the impact of ASS1 dysregulation on metabolic reprogramming of tumor cells
Xia, J., Liu, W., Ni, Y., Shahzad, A., Cui, K., Xu, Z., Zhang, J., Wei, Z., Teng, Z., Yang, Z., et al. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111593 · Cited by 7
Meyer, F. B., Marx, C., Spangel, S. B., & Thierbach, R. (2021) · Biomolecules · doi:10.3390/biom11121831 · Cited by 7
Wang, Z., Li, J., Wang, L., Liu, Y., Wang, W., Chen, J., Liang, H., Chen, Y. Q., & Zhu, S. (2024) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-024-00535-3 · Cited by 7
The interlacing anticancer effect of pharmacologic ascorbate, chloroquine, and resveratrol
Makk‐Merczel, K., Varga, D., Hajdinák, P., & Szarka, A. (2024) · BioFactors · doi:10.1002/biof.2050 · Cited by 7
Tracing of Amino Acids Dynamics in Cell Lines Based on 18 O Stable Isotope Labeling
Eylem, C. C., Baysal, İ., Ciftci, S. Y., & Nemutlu, E. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.4c05015 · Cited by 7
Leptin decreases BC cell susceptibility to NK lysis via PGC1A pathway
Bouguerra, H., Amal, G., Clavel, S., Boussen, H., Louet, J., & Gati, A. (2020) · Endocrine Connections · doi:10.1530/ec-20-0109 · Cited by 7
Reid, M. A., Sanderson, S. M., & Locasale, J. W. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00009-8 · Cited by 9
Lee, Y., Itahana, Y., Ong, C. C., & Itahana, K. (2022) · Journal of Cell Science · doi:10.1242/jcs.259090 · Cited by 10
Clonal Heterogeneity Supports Mitochondrial Metabolism in Pancreatic CancerPreprint
Halbrook, C. J., Thurston, G., McCarthy, A., Nelson, B. S., Sajjakulnukit, P., Krall, A. S., Mullen, P. J., Zhang, L., Batra, S., Viale, A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.15.098368 · Cited by 7
Teng, H., Huang, H., Lin, C., Twu, Y., Yang, W., Lin, W., Lan, H., Lin, Y., & Hwang, W. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13736 · Cited by 6
A new approach to assess drug sensitivity in cells for novel drug discovery
Mazzarella, L., & Curigliano, G. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1437136 · Cited by 6
Skwarski, M., Bowler, E., Wilson, J. D., Higgins, G. S., & Hammond, E. M. (2020) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-030-49701-9_11 · Cited by 7
Plasma-Like Culture Medium for the Study of Viruses
Golikov, M. V., Bartosch, B., Smirnova, O. A., Ivanova, O. N., & Ivanov, A. V. (2022) · mBio · doi:10.1128/mbio.02035-22 · Cited by 7
Hepatocellular Carcinoma: the Impact of NAFLD
Allaire, M., Dupont, B., Nahon, P., Ganne-Carrié, N., & Nault, J. (2016) · Current Hepatology Reports · doi:10.1007/s11901-016-0303-0 · Cited by 3
Metformin as an immunomodulatory agent in enhancing head and neck squamous cell carcinoma therapies
Li, W., Liu, N., Chen, M., Liu, D., & Liu, S. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189262 · Cited by 5
Tumor acidosis supports cancer cell lipid uptake via a rapid transporter-independent mechanism
Severin, M., Hansen, R. B., Rolver, M. G., Hels, T., Maeda, K., Pardo, L. A., & Pedersen, S. F. (2025) · Journal of Cell Science · doi:10.1242/jcs.263688 · Cited by 5
Zhao, Y.-H., Linghu, T., Wang, Q., Qin, X., & Tian, J. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5c00667 · Cited by 5
Carlos‐Reyes, Á., Romero‐Garcia, S., & Prado-Garcı́a, H. (2024) · Metabolites · doi:10.3390/metabo14020103 · Cited by 4
Modelling and deciphering tumour metabolism in CRISPR screens
Zuber, J. A., & Palm, W. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00758-8 · Cited by 5
In search for symmetries in the metabolism of cancer
Gatto, F., & Nielsen, J. (2015) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1321 · Cited by 5
How to follow metabolic clues to find cancer’s Achilles heel
Marx, V. (2019) · Nature Methods · doi:10.1038/s41592-019-0331-0 · Cited by 5
Maintaining proton homeostasis is an essential role of the Warburg effect in proliferating cells
Yang, C., & Li, B. (2019) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2019.0151 · Cited by 5
Kim, B., Lee, J., Shin, J. S., Suh, J.-W., Jung, S., Hwang, G., Lee, H., & Lee, K. (2021) · Scientific Reports · doi:10.1038/s41598-021-02729-7 · Cited by 5
High-dose metformin induces a low-glucose dependent genotoxic stress
Lyu, T., Zhou, H., Wang, Y., Jiang, M., Tao, Q., Chen, J., Guo, Y., Zhang, Q., Wang, X., & Guo, X. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.113129 · Cited by 5
Glycome Profiling of Cancer Cell Lines Cultivated in Physiological and Commercial Media
Wang, J., Peng, W., Yu, A., Fokar, M., & Mechref, Y. S. (2022) · Biomolecules · doi:10.3390/biom12060743 · Cited by 5
Metformin Impairs Linsitinib Anti-Tumor Effect on Ovarian Cancer Cell Lines
Almeida-Nunes, D. L., Silva, J. P. N., Nunes, M., Silva, P. M. A., Silvestre, R., Dinis‐Oliveira, R. J., Bousbaa, H., & Ricardo, S. A. V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252211935 · Cited by 4
Capelletti, M. M., Montini, O., Ruini, E., Tettamanti, S., Savino, A. M., & Sarno, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms26010045 · Cited by 4
Shangguan, F., Zhou, H., Zhang, H., Thaiyuri, R., Bryan, M. P., Cui, R., Lin, J., Chen, Y., & Zheng, Y. (2025) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2025.111584 · Cited by 4
Liu, R., Zhao, M., Zhang, X., Wu, H., Ren, L., Lv, J., Liu, Z., Wang, Q., & Yao, Z. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116163 · Cited by 4
Mitochondrial metabolism determines chemotherapy sensitivity in colorectal cancer
Moss, D. Y., Brown, C. N., Shaw, A. M., McCann, C., Lewis, N., Downs, M., Wurelly, R., Cunningham, C., Philips, A., Doherty, N., et al. (2026) · Nature Metabolism · doi:10.1038/s42255-026-01578-w · Cited by 9
Xiong, J., Xiong, S., Xi, F., Zhang, H., & Su, Q. (2022) · BioMed Research International · doi:10.1155/2022/2587120 · Cited by 4
RetractedCarta, S., Cossu, V., Vitale, F., Bauckneht, M., Ghelardoni, M., Orengo, A. M., Losacco, S., Gaglio, D., Bruno, S., Chiesa, S., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e38718 · Cited by 4
Zhang, Y., Xiang, S., Wu, Y., Yang, C. H., Tang, D., Chen, Z., & Huang, Z. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107978 · Cited by 4
The Role of Vitamin E in Breast Cancer Treatment and Prevention: Current Perspectives
de Oliveira, V. A., Pereira, I. C., Nogueira, T. R., Martins, J. A., Péres-Rodrigues, G., Freitas, B. D. J. E. S. D. A., Silva, V. C., Dittz, D., Torres‐Leal, F. L., Sousa, J. M. D. C. E., et al. (2020) · Current Nutrition & Food Science · doi:10.2174/1573401316999200614164711 · Cited by 4
Wang, B.-Z., Zhou, Y.-C., Lin, Y.-W., Chen, X., Yu, Z.-Y., Xu, Y., Tan, J., Huang, Z., & Chen, S.-B. (2023) · Molecules · doi:10.3390/molecules28062690 · Cited by 4
Cellular features predicting susceptibility to ferroptosis: insights from cancer cell-line profiling
Viswanathan, V. S. (2015) · doi:10.7916/d8h9940v · Cited by 4
Personalized Tumor Growth Prediction Using Multiscale Modeling
Ünsal, S., Acar, A. C., İtik, M., Kabataş, A., Gedikli, Ö., Özdemir, F., & Turhan, K. (2020) · Journal of Basic and Clinical Health Sciences · doi:10.30621/jbachs.2020.1245 · Cited by 4
Commentary: Inhibitors of mitochondrial respiratory chain in the treatment of type 2 diabetes
Ye, J. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.03.016 · Cited by 4
Wang, J., Peng, W., Yu, A., Fokar, M., & Mechref, Y. S. (2022) · Biomolecules · doi:10.3390/biom12111575 · Cited by 3
Abbott, K. L., Ali, A., Reinfeld, B. I., Deik, A., Subudhi, S., Landis, M. D., Hongo, R. A., Young, K. L., Kunchok, T., Nabel, C. S., et al. (2024) · eLife · doi:10.7554/elife.95652.3 · Cited by 3
Self-citationRecent advances in the design of small molecules targeting human ClpP
Shu, Z., Zhang, J., Wu, Y. C., Yang, T., & Luo, Y. (2025) · Future Medicinal Chemistry · doi:10.1080/17568919.2025.2557175 · Cited by 3
Chinopoulos, C. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104224 · Cited by 3
Kong, Q., Zhu, Q., Yang, Y., Wang, W. J., Qian, J., & Chen, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34442 · Cited by 3
Jo, S., Seo, M., Nguyen, T. H., Cha, J. W., An, Y. J., & Park, S. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c11809 · Cited by 3
Rotbain, E. C., Rostgaard, K., Kaastrup, K., Mikkelsen, S. U., Hjalgrim, H., & Grønbæk, K. (2025) · Acta Oncologica · doi:10.2340/1651-226x.2025.42422 · Cited by 3
Balancing the cellular budget: Lessons in metabolism from microbes to cancer
Vibishan, B., Jolly, M. K., & Goyal, A. (2025) · Biosystems · doi:10.1016/j.biosystems.2025.105571 · Cited by 3
Mitochondria And Cancer: The Warburg Fact
Taanman, A. M. K. J. W. (2014) · Chemotherapy Open access · doi:10.4172/2167-7700.1000134 · Cited by 3
Takino, J.-I., Sato, T., Hiraishi, I., Nagamine, K., & Hori, T. (2021) · Biology · doi:10.3390/biology10010057 · Cited by 3
Valle, M. M. R., Vilas‐Boas, E. A., Lucena, C. F., Teixeira, S. A., Muscará, M. N., & Carpinelli, Â. R. (2022) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23007 · Cited by 3
Dialysis as a Novel Adjuvant Treatment for Malignant Cancers
Hobro, S., Nilsson, A., Sternby, J., Öberg, C. M., Pietras, K., Axelson, H., Carneiro, A., Kinhult, S., Christensson, A. G., Fors, J., et al. (2022) · Cancers · doi:10.3390/cancers14205054 · Cited by 3
Heterogeneity of Amino Acid Profiles of Proneural and Mesenchymal Brain-Tumor Initiating Cells
Seliger, C., Rauer, L., Wüster, A.-L., Moeckel, S., Leidgens, V., Jachnik, B., Ammer, L.-M., Heckscher, S., Dettmer, K., Riemenschneider, M. J., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043199 · Cited by 3
A resource-based mechanistic framework for castration-resistant prostate cancer (CRPC)
Vibishan, B., Harshavardhan, B. V., & Dey, S. (2024) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2024.111806 · Cited by 3
Insights into pancreatic β cell energy metabolism using rodent β cell models
Morten, K., Potter, M., Badder, L. M., Sivathondan, P., Dragovic, R., Neumann, A., Gavin, J. R., Shrestha, R., Reilly, S. N., Phadwal, K., et al. (2017) · Wellcome Open Research · doi:10.12688/wellcomeopenres.10535.3 · Cited by 5
Baptista, L. P. R., Sinatti, V. V. C., Silva, J. H. M. D., Dardenne, L. E., & Guimarães, A. C. R. (2019) · Advances and Applications in Bioinformatics and Chemistry · doi:10.2147/aabc.s197119 · Cited by 3
Marciano, R., Ben-David, H., Akabayov, B., & Rotblat, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031041 · Cited by 3
Berstein, L. M., Vasilyev, D. A., Iyevleva, A. G., Boyarkina, M. P., Евгеньевна, П. Т., Khadzhimba, A. S., & Имянитов, Е. Н. (2015) · Future Oncology · doi:10.2217/fon.14.317 · Cited by 3
Wei, X., Xiang, Z., Xue, W., & Chen, S. (2022) · ACS Applied Nano Materials · doi:10.1021/acsanm.2c03880 · Cited by 3
Fructose, Another Sweet for Cancer: A Context Acting Nutrient Hypothesis
Koltai, T., & Fliegel, L. (2023) · Gene Expression · doi:10.14218/ge.2023.00014 · Cited by 2
NADH as a cancer medicinePreprint
Forrest, M. (2015) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/019307 · Cited by 3
Forrest, M. (2015) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/035113 · Cited by 3
Kuś, K., Treherne, J. M., Earnshaw, D. L., Krzykawska, R., Biesaga, B., Statkiewicz, M., Unrug-Bielawska, K., Sandowska-Markiewicz, Z., Mikuła, M., Alfaro, J. A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.08.583569 · Cited by 3
Metadata
- Authors
- Birsoy, K., Possemato, R., Lorbeer, F. K., Bayraktar, E. C., Thiru, P., Yucel, B., Wang, T., Chen, W. W., Clish, C. B., & Sabatini, D. M.
- Affiliations
- Broad Institute (US)
- Whitehead Institute for Biomedical Research (US)
- Corresponding author
- Sabatini, David M.
- ORCID
- Venue
- Nature
- Published
- 2014-03-16
- Volume
- 508
- Issue
- 7494
- Pages
- 108-112
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4012432
- OpenAlex
- W2104696999
- Cited by
- 710
- References
- 27
- Citations by year
- 2026: 17 · 2025: 44 · 2024: 58 · 2023: 46 · 2022: 60 · 2021: 75 · 2020: 83 · 2019: 71 · 2018: 51 · 2017: 49 · 2016: 61 · 2015: 59 · 2014: 35
- FWCI
- 21.80
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Cancer Institute (CA129105, K99CA168940, CA103866, R01CA103866, R01CA129105, R00CA168940)
- National Institute of General Medical Sciences (T32GM007287)
- National Institute of Allergy and Infectious Diseases (AI-07389, T32AI007389)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK043351)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- glucose limitation, biguanides, mitochondrial oxidative phosphorylation, cancer metabolism, mitochondrial DNA mutations, complex I, antidiabetic drugs, OXPHOS inhibitors, continuous flow culture, tumor microenvironment, NDI1, glucose utilization, cancer cell lines, drug sensitivity biomarkers
- MeSH terms
- Adenosine Triphosphate, Animals, Biguanides, Culture Media, DNA, Mitochondrial, Glucose, Humans, Hypoglycemic Agents, Male, Mitochondria, Mutation, Neoplasm Transplantation, Neoplasms, Oxidative Phosphorylation, Phenformin, Cell Culture Techniques, Xenograft Model Antitumor Assays, Saccharomyces cerevisiae Proteins, RNA Interference, Electron Transport Complex I, Cell Line, Tumor, Cell Proliferation, Mice, Molecular Typing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
